These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32221634)

  • 1. [Past and future of the ESUS concept].
    Diener HC; Endres M
    Nervenarzt; 2020 Jun; 91(6):511-517. PubMed ID: 32221634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review and update of the concept of embolic stroke of undetermined source.
    Diener HC; Easton JD; Hart RG; Kasner S; Kamel H; Ntaios G
    Nat Rev Neurol; 2022 Aug; 18(8):455-465. PubMed ID: 35538232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    Ntaios G
    J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
    Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
    Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
    Diener HC; Bernstein R; Hart R
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embolic Stroke of Undetermined Source: Gateway to a New Stroke Entity?
    Schäbitz WR; Köhrmann M; Schellinger PD; Minnerup J; Fisher M
    Am J Med; 2020 Jul; 133(7):795-801. PubMed ID: 32247819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
    Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG;
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ten key messages regarding embolic stroke of undetermined source and cryptogenic stroke].
    Böttger P; Grond M; Lemm H; Buerke M
    Med Klin Intensivmed Notfmed; 2018 Nov; 113(8):664-671. PubMed ID: 30155725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
    Diener HC; Sacco RL; Easton JD; Granger CB; Bar M; Bernstein RA; Brainin M; Brueckmann M; Cronin L; Donnan G; Gdovinová Z; Grauer C; Kleine E; Kleinig TJ; Lyrer P; Martins S; Meyerhoff J; Milling T; Pfeilschifter W; Poli S; Reif M; Rose DZ; Šaňák D; Schäbitz WR
    Stroke; 2020 Jun; 51(6):1758-1765. PubMed ID: 32404035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolic strokes of undetermined source: theoretical construct or useful clinical tool?
    Tsivgoulis G; Katsanos AH; Köhrmann M; Caso V; Lemmens R; Tsioufis K; Paraskevas GP; Bornstein NM; Schellinger PD; Alexandrov AV; Krogias C
    Ther Adv Neurol Disord; 2019; 12():1756286419851381. PubMed ID: 31205494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
    Veltkamp R; Pearce LA; Korompoki E; Sharma M; Kasner SE; Toni D; Ameriso SF; Mundl H; Tatlisumak T; Hankey GJ; Lindgren A; Berkowitz SD; Arauz A; Ozturk S; Muir KW; Chamorro Á; Perera K; Shuaib A; Rudilosso S; Shoamanesh A; Connolly SJ; Hart RG
    JAMA Neurol; 2020 Oct; 77(10):1233-1240. PubMed ID: 32628266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
    Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M
    JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reexamination of the Embolic Stroke of Undetermined Source Concept.
    Albers GW; Bernstein R; Brachmann J; Camm AJ; Fromm P; Goto S; Granger CB; Hohnloser SH; Hylek E; Krieger D; Passman R; Pines JM; Kowey P
    Stroke; 2021 Aug; 52(8):2715-2722. PubMed ID: 34192898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source　- Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.
    Toyoda K; Uchiyama S; Hagihara Y; Kuwashiro T; Mori T; Kamiyama K; Urano Y; Taniguchi A; Nozaki K; Cronin L; Grauer C; Brueckmann M; Diener HC
    Circ J; 2020 Nov; 84(12):2286-2295. PubMed ID: 33132228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
    Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R
    JAMA Neurol; 2021 Dec; 78(12):1454-1460. PubMed ID: 34694346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.
    Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG;
    Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
    Diener HC; Sacco RL; Easton JD; Granger CB; Bernstein RA; Uchiyama S; Kreuzer J; Cronin L; Cotton D; Grauer C; Brueckmann M; Chernyatina M; Donnan G; Ferro JM; Grond M; Kallmünzer B; Krupinski J; Lee BC; Lemmens R; Masjuan J; Odinak M; Saver JL; Schellinger PD; Toni D; Toyoda K;
    N Engl J Med; 2019 May; 380(20):1906-1917. PubMed ID: 31091372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non vitamin K oral anticoagulants versus antiplatelets in embolic stroke of undetermined source: most updated evidence.
    Chatterjee S; Dubey S; Lahiri D; Ray BK
    Minerva Cardioangiol; 2019 Aug; 67(4):340-347. PubMed ID: 31220915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.